The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP2263688
WO Application Number:
Type:
European Patent Granted for NL
Status:
Expired. Art. 36.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP10007477.2
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:
Dates
Filing date:
20/06/2002
Grant date:
09/05/2012
EP Publication Date:
22/12/2010
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
27/02/2020
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
09/05/2012
EP B1 Publication Date:
09/05/2012
EP B2 Publication Date:
25/12/2019
EP B3 Publication Date:
Description Translation B1 Received Date:
06/07/2012
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
19/06/2022
Lapsed By Expiration Date:
20/06/2022
Patent Validated Date:
20/03/2020
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
22/12/2021
Name:
GlaxoSmithKline Biologicals S.A.
Address:
Rue de l'Institut 89, 1330, Rixensart, Belgium (BE)
European patents granted in amended form for the Netherlands in which an amended translation was filed ex Article 52 par. 6 of the NL Patent Law 1995
4
Bulletin Heading:
EP4
Journal edition number:
53/19
Publication date:
01/01/2020
Description:
European patents granted in amended form for the Netherlands
5
Bulletin Heading:
MED
Journal edition number:
53/19
Publication date:
01/01/2020
Description:
Other communications
6
Bulletin Heading:
VB1
Journal edition number:
2013/13
Publication date:
27/03/2013
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention
7
Bulletin Heading:
EP3
Journal edition number:
2012/28
Publication date:
11/07/2012
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
8
Bulletin Heading:
EP2
Journal edition number:
2012/20
Publication date:
16/05/2012
Description:
European patents granted for the Netherlands
European Patent Bulletin
1
Issue number:
201952
Publication date:
25/12/2019
Description:
Patent maintained (B2 publication)
2
Issue number:
201312
Publication date:
20/03/2013
Description:
Opposition procedure started
3
Issue number:
201219
Publication date:
09/05/2012
Description:
Grant (B1)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
RC202102715A
Date Registered:
22/12/2021
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
Name:
GlaxoSmithKline Biologicals S.A.
Address:
Rue de l'Institut 89, 1330, Rixensart, Belgium (BE)